key: cord-0820702-wrcoqec9 authors: d'Annunzio, Giuseppe; Maffeis, Claudio; Cherubini, Valentino; Rabbone, Ivana; Scaramuzza, Andrea; Schiaffini, Riccardo; Minuto, Nicola; Piccolo, Gianluca; Maghnie, Mohamad title: Caring for children and adolescents with type 1 diabetes mellitus: italian society for pediatric and adolescent diabetes (ISPED) Statements during COVID-19 pandemia date: 2020-08-20 journal: Diabetes Res Clin Pract DOI: 10.1016/j.diabres.2020.108372 sha: f63dece97fa52c18e7177d0d8ded9465b05e384b doc_id: 820702 cord_uid: wrcoqec9 Abstract Aims Our study aimed to review the impact of COVID-19 pandemia in children and adolescents with type 1 diabetes mellitus, to analyze the clinical characteristics of the infection and to propose clinical practice recommendations from the Italian Society for Pediatric and Adolescent Endocrinology (ISPED). Methods A literature search was carried out in the guideline databases, Medline and Embase and in Diabetes Societies websites until May 21st, 2020 for guidelines and recommendations on type 1 diabetes mellitus management during COVID-19 pandemic. Results COVID-19 infection in pediatric patients seems to be clinically less severe than in adults, and children have so far accounted for 1-5% of diagnosed cases, and a median age of 6.7 years (1 day-15 years) with better prognoses. Clinical manifestations include mild, moderate, severe disease up to critical illness. There is currently no evidence suggesting a higher risk of COVID-19 infection in children with diabetes than unaffected peers. Besides general recommendation for pediatric patients, ISPED has proposed specific measures for patients with diabetes. Conclusion COVID-19 outbreak modified type 1 diabetes management, and telemedicine has been demonstrating to be an effective new tool for patients care. Moreover psychological aspects deserve attention and future researchs are mandatory. In December 2019 a new RNA betacoronavirus infection emerged in Wuhan, China [1] . It has been recognized as causative factor of severe pneumonia and other systemic complications [1] . At the end of January, 2020, the WHO named this betacoronavirus infection COVID-19 and defined it as a global epidemic communicable form of pneumonia. The disease spread rapidly worldwide and by March 11 the COVID-19 outbreak was classified as a pandemic disease [2] . factors [3] . The most recognized form of COVID-19 transmission is through large respiratory droplets. The virus has been also found in tears, urine and stool of affected individuals [4] . The clinical features of the COVID-19 infection vary from being asymptomatic to fever, dry cough and fatigue up to acute respiratory distress syndrome with multiorgan involvement and death [5] . Other symptoms include sore throat, headache, abdominal pain and diarrhea. Median age of infected individuals is in 50s, with a prevalence of male gender [4] . Infected adult patients who developed acute respiratory distress syndrome were usually affected by other co morbidities [5] . The aim of our study was to analyze available data about COVID-19 infections and type 1 diabetes mellitus, and to formulate recommendations for children and adolescents with or who may develop type 1 diabetes mellitus in the time of Covid-19 infection. A literature search was carried out in the guideline databases, Medline and Embase and in Diabetes COVID-19 infection in pediatric patients seems to be clinically less severe than in adults, and children have so far accounted for 1-5% of diagnosed cases, and a median age of 6.7 years (1 day-15 years) with better prognoses [6] [7] [8] [9] . The hypothesis that children are less susceptible to COVID-19 is intriguing, since newborn and infants can be infected, even if vertical transmission has not been certainly ruled out [10, 11] ; a lower risk has been recently ascribed to an age-dependent expression of angiotensin-converting enzyme 2 (ACE2). ACE2 in nasal epithelium isthe first point of contact for SARS-CoV-2 and the human body [12] . Incubation period is about 1-14 days, up to 24 days. Children affected by COVID-19 infection are generally asymptomatic increasing the risk of prolonged spreading of the outbreak. In fact, in more than 90% of affected children, the infection is clinically silent or is characterized by mild to moderate disease, while, in 5.2% of cases, severe form and in 0.6% critical illness have been described [7] . in addition to the common symptoms (44% of the patients presented with cough), also other more specific symptoms of early childhood, such as no feeding or feeding difficulties (23% of children). In this cohort 9 patients received respiratory support [16] . Previous observations report an increased susceptibility to infections among patients with both type 1 and type 2 diabetes mellitus, responsible of increased morbidity and mortality [17] [18] [19] [20] . Hyperglycemia may increase the virulence of different pathogens by enhancing bacterial replication and facilitating their attachment to epithelial cells favoring immune system dysfunction, [21] [22] [23] . A study aimed to evaluate humoral factors in pediatric patients with type 1 diabetes showed lower IgG and C3 levels in poorly controlled disease as compared to patients with satisfactory degree of metabolic control [24] . Moreover, several viral infections have been considered as possible triggers of the autoimmune process leading to clinically overt type 1 diabetes mellitus, and infectious diseases may accelerate the clinical onset in at risk subjects [25] [26] [27] [28] . Several case reports describe severe infections both in affected children and adults and underline the importance of considering infectious diseases prompt diagnosis, treatment and, when available, prevention as goal for good management of the disease [29] [30] [31] [32] . Similarly, diabetic ketoacidosis recovery may be delayed by concomitant infectious disease [33] . A US study in 77% type 1 and 23% type 2 diabetes adolescents reported that respiratory infections were the most common kind of infections, responsible for emergency care, hospitalization and increased economic impact and health care cost [34] . for patients, especially for seasonal influenza and pneumococcal infection [35] . Despite several evidence suggests the importance of vaccination in patients with diabetes mellitus, and the lack of association between vaccinations and autoimmunity [36] , global coverage is still lower than expected [37] [38] [39] [40] [41] [42] . As regards previous MERS and SARS outbreaks, to our knowledge no data are available regarding clinical course and sequelae in pediatric patients. On the other hand vaccination against H1N1 virus was not associated with increased risk of islet autoimmunity or type 1 diabetes, and in a group of Italian patients we did not report an increased risk of hospitalization due to H1N1 infection in pediatric patients with type 1 diabetes [43] . Adult patients with diabetes are included in high risk group for COVID-19 infection with high mortality and morbidity rate. Diabetes mellitus and COVID-19 infection might share more links than expected. Both diseases represent a severe pandemics and are characterized by multiorgan involvement, even if with peculiar differences: chronic versus acute condition, communicable versus non communicable, both with unknown, at present, and known long-term complications. Even if common opinion associates diabetes with higher morbidity and mortality due to infections, it is still unknown if and how it represents a risk factor for prognosis of COVID-19. Diabetes mellitus is indeed one of the most frequent comorbidities observed in patients with COVID-19 infection. Some authors described that patients with severe disease, as compared with subjects with more mild infection, had diabetes as a common co morbidity [44] . On the other hand, since in patients with diabetes any infectious disease worsens the degree of metabolic control with a negative effect on the recovery, also COVID-19 infection may generate a vicious circle that would be detrimental for a better prognosis. It is also important to consider that COVID-19 receptors ACE2 are expressed on several organ and tissues, with a consequent risk of multiorgan failure other than lung involvement [45] . A recent study aimed to establish if diabetes is a risk factor influencing the outcome and prognosis of COVID-19 reported that adult patients without other co morbidities were at higher risk of severe pneumonia, showed higher tissue enzyme levels indicating multiorgan involvement, uncontrolled inflammatory response and hypercoagulable state together with dysregulation of metabolic control, even if insulin requirement increased after infection [46] . Worsening of metabolic control affects severity of pneumonia, together with the coexistence of comorbidities. Therefore, diabetes should be considered as a risk factor for the inflammatory storm leading to rapid worsening of COVID-19 infection. Potential mechanisms increasing the risk of COVID-19 among patients with diabetes are higher affinity cellular binding and efficient virus entry into the cells, decreased virus clearance, reduced T cell function, increased susceptibility to cytokine storm [47] . Increased expression of ACE2 has been observed in the lung, kidney, heart, pancreas in animal models of diabetes [48] . Moreover, higher levels of furin, a cellular protease facilitating virus entry, have been observed in patients with diabetes mellitus [49] . As for the impact of diabetes among adults COVID-19 infected Italian patients, it has been reported that the prevalence of pre-existing diabetes was 8.9%, and the ratio of diabetes in patients who died for COVID-19 infection as compared to general population was 1.75 [50] . inhibitors might reduce the severity of lung inflammation [53] . As for H1N1 viral infection as possible risk factor for diabetes, it has been reported that H1N1 strains are able to infect and replicate in mammalian pancreatic cells both in vitro and in vivo, but are not associated with clinical onset of diabetes mellitus [54] . At present, there is no association between COVID-19 infection and the increased risk of type 1 diabetes: future studied are needed to better define the role of COVID-19 and autoimmunity. The COVID-19 infection seems to be unusual among patients with type 1 diabetes mellitus, although they are considered a fragile population. It has been hypothesized that the peculiar immune condition that leads to the destruction of the beta cells might play an important role [55] . On the other hand, the risk of increased frequency of severe ketoacidosis in new-onset type 1 diabetes due to delayed diagnosis -because of fear of contracting COVID-19 in a hospital setting, or inability to contact a medical provider for timely evaluation -should be considered [56] . Similarly, parents of patients with poor glycemic control requiring closer follow-up might postpone the appointments for the same reasons. Table 1 reports a summary of data extracted from studies looking at clinical characteristics of COVID-19 infection and its impact in patients affected by diabetes mellitus. Several pediatric diabetes centers have developed and implemented telemedicine services, thus allowing patients to remain in close contact with the team, to share glycemic data and insulin dosage, and to adapt disease management without close person-to-person contact, thus minimizing the risk of infection and of metabolic decompensation [57] . Benefit of telemedicine included prevention of ketoacidosis in long-standing patients thanks to remote monitoring [58] . In fact remote glycemic monitoring through cloud platforms has enabled pediatric diabetologists to obtain a closer interaction with patients during the pandemic lockdown. Thanks to telemedicine patients are now evaluated safely and more frequently, every week or two according to the degree of metabolic control. Telehealth is not only limited to glycemic control, but need to be extended to all diabetic team, including diabetes educators, dietician, psychologist [59] . Several pediatric teams with a dedicated dietician have prepared specific weekly food plans in order to prevent inappropriate excessive caloric intake, especially in this period of reduced physical exercise. On the other hand, promotion of physical exercise even during quarantine was followed by an improvement of metabolic control [60] . Moreover, periodical teleconsult with psychologist has been guaranteed to help patients and families to cope with this stressful period and has been well accepted by both patients and families. Besides general recommendation for pediatric patients (Table 2) , ISPED has proposed specific measures for patients with diabetes (Table 3) . International Society for Pediatric and Adolescents Diabetes (ISPAD) must be followed, together with specific treatment for the infection [64] . In case of hospitalization, a multidisciplinary management of the affected patients by strict cooperation between pediatric diabetologist and other physicians is mandatory. For adolescents with type 2 diabetes treated with metformin or other antidiabetic drugs, oral agents may need to be stopped, and insulin treatment considered for glucose control when hospitalized [65] . COVID-19 outbreak has removed many long-standing regulatory burdens to telehealth, and it is now assumed that telemedicine is a new safe and effective way for remote diabetes management [66] . Future research are needed to evaluate the impact of COVID-19 in type 1 diabetes mellitus patients, regarding not only its hypothetical role in disease epidemiology, but also the implementation of new management strategies, the short-and long-term impact of telemedicine as current tool for diabetes care. At present the recovery from COVID-19 pandemia is unpredictable, therefore the development of new alternative approaches to manage patients with diabetes is mandatory. The pandemia has There is currently no evidence suggesting a higher risk of COVID-19 infection in children with diabetes than unaffected peers. In addition, contrary to adult patients with diabetes, there are no reports suggesting that diabetes is a comorbidity associated with poor outcomes in children and Epidemiological characteristics and prevention and control measures of Corona Virus Disease 2019 in children World Health Organization. WHO characterizes COVID-19 as a pandemic. 1.1 (EB/OL The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? COVID-19-New insights on a rapidly changing epidemic Risk Factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China Are children less susceptible to COVID-19? Systematic review of covid-19 in children shows milder cases and a better prognosis than adults World Health Organization. Coronavirus disease 2019 (COVID-19): situation report 65 Italian National Health Institute (Istituto Superiore di Sanità) Novel coronavirus infection in hospitalized infants under 1 year of age in China Clinical characteristics of novel coronavirus disease 2019 (COVID-19) in newborns, infants and children Evidence and possible mechanisms of rare maternal-fetal transmission of SARS-CoV-2 Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study Clinical and CT features in pediatric patients with COVID-19 infection: different points from adults Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study The mortality in infectious in patients with type 2 diabetes compared with nondiabetic population: Infection in type 2 diabetes Mortality from infectious diseases in diabetes Infections in patients with diabetes mellitus: a review of pathogenesis Outcomes of hyperglycemia in patients with and without diabetes hospitalized for infectious diseases Poorly regulated blood glucose in diabetic patients-predictor of acute infections Is immunity in diabetic patients influencing the susceptibility to infections? Immunoglobulins, complement and phagocytic function in children and adolescents with type 1 diabetes mellitus Viruses in type 1 diabetes Enteroviral infections as a trigger for type 1 diabetes The diabetes pandemic and associated infections: suggestions for clinical microbiology Type 1 diabetes and measles, mumps and rubella childhood infections within the Italian Insulin-dependent Diabetes Registry Iliopsoas abscess in adolescents with type 1 diabetes mellitus Helicobacer pylori infection in children with type 1 diabetes: a case control study Frequency of urinary tract infection and antibiotic sensitivity of uropathogens in patients with diabetes Patients with type 1 diabetes mellitus have impaired IL-1β production in response to Mycobacterium tuberculosis Difficulties or mistakes in diagnosing type 1 diabetes in children?-demographic factors influencing delayed diagnosis The burden of common infections in children and adolescents with diabetes mellitus: a Pediatric Health Information System study Standards of medical care in diabetes-2012 Vaccinations and childhood type 1 diabetes mellitus: a meta-analysis of observational studies Flu vaccination among patients with diabetes: motives, perceptions, trust, and risk culture -a qualitative survey Hepatitis B vaccination coverage in patients with diabetes mellitus antibody responses to immunizations in children with type 1 diabetes mellitus: a case-control study Children with type 1 diabetes mellitus: access to special immunobiological and child care TEDDY Study Group. Pandemrix® vaccination is not associated with increased risk of islet autoimmunity or type 1 diabetes in the TEDDY study children. Version 2 Italian Pneumococcal Study Group on Diabetes. Streptococcus pneumoniae oropharyngeal colonization in school-age children and adolescents with type 1 diabetes mellitus: Impact of the heptavalent pneumococcal conjugate vaccine Pandemic influenza vaccination coverage in children with type 1 diabetes: analysis from seven Italian centers Diabetes and Covid-19: a global health challenge Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan China: a descriptive study Diabetes is a risk factor for the progression and prognosis of COVID-19 Perspective: COVID-19 pandemic, coronaviruses, and diabetes mellitus ACE and ACE2 activity in diabetic mice Plasma levels of the proprotein convertase furin and incidence of diabetes and mortality Prevalence and impact of diabetes among people infected with SARS-CoV-2 Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes Coronavirus disease (COVID-19) infection and renin angiotensin system blockers Study of 2009 H1N1 pandemic influenza virus as a possible causative agent of diabetes The CoV-19 infection appears to be unusual among patients with type 1 diabetes mellitus, although they are considered a fragile population. We think that this in part due to the peculiar immune condition that leads to the destruction of the beta cells Unintended consequences of COVID-19: Remember general pediatrics Telemedicine consultations and diabetes technology during COVID-19 The silver lining to COVID-19: Avoiding diabetic ketoacidosis admissions with telehealth Glycemic control in type 1 diabetes mellitus during covid-19 quarantine and the role of in-home physical activity Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China A tale of two pandemics: How will COVID-19 and global trends in physical inactivity and sedentary behavior affect one another? Prog Cardiovasc Dis Health-related Quality of Life of adolescents with type 1 diabetes in the context of resilience ISPAD Clinical Practice Consensus Guidelines 2018: Sick day management in children and adolescents with diabetes Clinical considerations for patients with diabetes in times of COVID-19 epidemic Table 2: General recommendations • Stay at home, avoid crowded places • Wash your hands, don't touch eyes, nose and mouth • Cover mouth and nose with bent elbow or tissue when coughing or sneezing • Avoid contacts with other persons • Don't interrupt vaccination program We gratefully thank Dr. Flavia Napoli MD for English revision Funding source: This research did not receive any specific grant from funding agencies in the public, commercial or not-profit sections The authors declare no conflict of interest.